Prot# TTX404: A Phase 3, Multicenter, Randomized Study To Evaluate The Substitution Of Marqibo (Vincristine Sulfate Liposomes Injection, VSLI) For Standard Vincristine Sulfate Injection (VSI) In The Induction, Intensification, And Maintenance Phases Of Co